Intervention Review

Aripiprazole versus placebo for schizophrenia

  1. Ravindra B Belgamwar1,*,
  2. Hany George G El-Sayeh2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 10 AUG 2011

Assessed as up-to-date: 19 SEP 2010

DOI: 10.1002/14651858.CD006622.pub2


How to Cite

Belgamwar RB, El-Sayeh HGG. Aripiprazole versus placebo for schizophrenia. Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD006622. DOI: 10.1002/14651858.CD006622.pub2.

Author Information

  1. 1

    Lymebrook Mental Health Centre, Newcastle Under Lyme, Staffordshire, UK

  2. 2

    Harrogate District Hospital, Briary Wing, Harrogate, West Yorkshire, UK

*Ravindra B Belgamwar, Lymebrook Mental Health Centre, Bradwell Hospital Site, Newcastle Under Lyme, Staffordshire, ST5 4LD, UK. ravindrab.belgamwar@northstaffs.nhs.uk. ravindrab.belgamwar@northstaffs.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 10 AUG 2011

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.